The degree of hepatic steatosis associates with impaired cardiac and autonomic function

JOURNAL OF HEPATOLOGY

卷:70

Article

Houghton, David¹  Zalewski, Pawel³  Hallsworth, Kate¹  Cassidy, Sophie¹  Thoma, Christian¹  Avery, Leah¹  Slomko, Joanna³  Hardy, Timothy^1,2  Burt, Alastair D.⁴  Tiniakos, Dina^1,5  Hollingsworth, Kieren G.¹  Taylor, Roy¹  Day, Christopher P.^1,2  Masson, Steven^1,2  McPherson, Stuart^1,2  Anstee, Quentin M.^1,2  Newton, Julia L.^1,2  Trenell, Michael, I¹ 

[1] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England

[2] Newcastle Tyne Hosp NHS Trust, Freeman Hosp, Liver Unit, Newcastle Upon Tyne, Tyne & Wear, England

[3] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Fac Hlth Sci, Dept Hyg Epidemiol & Ergon, M Sklodowskiej Curie 9, PL-85094 Bydgoszcz, Poland

[4] Univ Adelaide, Fac Hlth Sci, Level 2,North Terrace, Adelaide, SA 5005, Australia

[5] Univ Athens, Aretaieion Hosp, Dept Pathol, Athens 11528, Greece

关键词: Liver fat;    Cardiac;    Autonomic;    Alcohol;    Inflammation;   

DOI  :  10.1016/j.jhep.2019.01.035

来源: Elsevier

【 摘 要 】

Background & Aims: Cardiovascular disease is the principle cause of death in patients with elevated liver fat unrelated to alcohol consumption, more so than liver-related morbidity and mortality. The aim of this study was to evaluate the relationship between liver fat and cardiac and autonomic function, as well as to assess how impairment in cardiac and autonomic function is influenced by metabolic risk factors. Methods: Cardiovascular and autonomic function were assessed in 96 sedentary individuals: i) non-alcoholic fatty liver disease (NAFLD) (n = 46, hepatic steatosis >5% by magnetic resonance spectroscopy), ii) Hepatic steatosis and alcohol (dual aetiology fatty liver disease [DAFLD]) (n = 16, hepatic steatosis >5%, consuming >20 g/day of alcohol) and iii) CONTROL (n = 34, no cardiac, liver or metabolic disorders, <20 g/day of alcohol). Results: Patients with NAFLD and DAFLD had significantly impaired cardiac and autonomic function when compared with controls. Diastolic variability and systolic variability (LF/HF-sBP [n/1]; 2.3 (1.7) and 2.3 (1.5) vs. 3.4 (1.5), p < 0.01) were impaired in patients with NAFLD and DAFLD when compared to controls, with DAFLD individuals showing a decrease in diastolic variability relative to NAFLD patients. Hepatic steatosis and fasting glucose were negatively correlated with stroke volume index. Fibrosis stage was significantly negatively associated with mean blood pressure (r = -0.47, p = 0.02), diastolic variability (r = -0.58, p <= 0.01) and systolic variability (r = -0.42, p = 0.04). Hepatic steatosis was independently associated with cardiac function (p <= 0.01); TNF-alpha (p <= 0.05) and CK-18 (p <= 0.05) were independently associated with autonomic function. Conclusion: Cardiac and autonomic impairments appear to be dependent on level of liver fat, metabolic dysfunction, inflammation and fibrosis staging, and to a lesser extent alcohol intake. Interventions should be sought to moderate the excess cardiovascular risk in patients with NAFLD or DAFLD. Lay summary: Increased levels of fat in the liver impair the ability of the cardiovascular system to work properly. The amount of fat in the liver, metabolic control, inflammation and alcohol are all linked to the degree that the cardiovascular system is affected. (C) 2019 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.

【 授权许可】

Free